Improving diagnostics with eye tracking
Current Tests
Upcoming Tests
Objective acuity
Objective contrast sensitivity
Ganglion layer dark adaptation
Saccade main sequence
Automated saccade metrics
Automated smooth pursuit metrics
Automated fixation metrics
Our purpose
Our aim is to offer clinicians and researchers one device that can perform multiple rapid neuro-ophthalmic eye examination tests. Our unique BulbiHUB platform and BulbiCAM currently offers the user multiple tests to screen for glaucoma, age-related macular degeneration (AMD) , nystagmus, cataract and optic neuritis. Ultimately our BulbiCAM will include multiple tests to screen for both ophthalmological and neurological conditions.
Our technology maintains good vision and cognitive health across a lifetime.
BulbiCAM - multiple rapid eye examination tests to screen for ophthalmological and neurological conditions
Benefits of our technology
- Rapid testing the afferent visual function and efferent system of patients
- One combined perimeter, pupillograph and nystagmograph
- Early detection of ophthalmological and neurological conditions
- Provides objective data of the afferent visual function and efferent system of patients
- Replaces manual examinations
- Patient does the work, not the clinician
- Integrates with any third party ophthalmic device
- Can be operated by ophthalmic nurse, tech staff or any other assistant
The problems we solve
- Long and difficult process of neuro-ophthalmic examination
- Manually performing the entrance and functional eye examination
- Manually inserting test results
- Inefficient clinical workflow
- Subjective interpretation
- Lack of data during clinical decision making
- Lack of research data on eye - brain functionality
Our clinical importance
Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having one single device available in daily clinical practice supporting eye doctors in a complete neuro-ophthalmic assessment of the patient.
Early detection of functional disorders with a dedicated platform and diagnostic device that replaces the manual examination and saves time
Decentralizing access to screening of ophthalmological and neurological conditions by introducing rapid eye examination tests
Rapid screening supports already understaffed eye care professionals to face an increase demand of eye care by providing them with a platform and diagnostic support device in which the patient does the work and can be operated by anyone
Generating objective data and clinical results to improve health outcome and research
BulbiCAM
Diagnostic tool in mastering a complete neuro-ophthalmic assessment of the patient
- 400-600 FPS eyetracking
- Two screens for independent presentation to each eye
- Accurate timing synchronization
- Calibration free eye tracking test setup
- Individual compensation of refractive errors and head shape
- Can be operated remotely via internet
- CE-certified & FDA registered
Our solution
BulbiHUB platform
BulbiHUB platform assesses the data measured by BulbiCAM. BulbiHUB is an innovative point-of-care eye platform for the screening of ophthalmological and neurological disorders.
Telemedicine
Assessed data can be shared between and amongst clinical from peripheral locations to one central location, resulting in a clinical workflow that can continue remotely during pandemic outbreaks
AI [Artificial Intelligence]
Algorithms can be developed to detect early stage neuro- ocular dysfunctions and analyze our collected data for research purpose
News
Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren
Article / News Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren, a magazine for Norwegian optometry & visual sciences. The article describes our clinical research with Oslo University Hospital, the University of South-East Norway and the collaboration with optician […]
Bulbitech is attending Medica 2021 from November 15 – 18 in Düsseldorf, Germany.
Article / News Bulbitech is attending Medica 2021 from November 15 – 18 in Düsseldorf, Germany. We cordially invite researchers, ophthalmologists, neurologists and local distributors / resellers of medical device to visit booth H15J02. Our booth design and location can be viewed below.
A haploscope based binocular pupillometer system to quantify the dynamics of direct and consensual Pupillary Light Reflex
Article / News A haploscope based binocular pupillometer system to quantify the dynamics of direct and consensual Pupillary Light Reflex Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikeren, a magazine for Norwegian optometry & visual sciences. The article describes our clinical research with Oslo University Hospital, the University of South-East Norway […]
Impression: Kick-off meeting “a paradigm shift in neuro-ophthalmic care” with Oslo University Hospital
Article / News Impression: Kick-off meeting “a paradigm shift in neuro-ophthalmic care” with Oslo University Hospital On Wednesday September 15th a kick-off meeting was held at the Eye Research Department of Oslo University Hospital. The kick-off meeting was organized with the aim to inform our clinical partners on the clinical research that will take place […]
2. BulbiCAM overview
2. BulbiCAM overview Overview of the BulbiCAM’s parts. Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn
BulbiCAM accessory unboxing
BulbiCAM accessory unboxing When you receive your BulbiCAM accessories please visually inspect the package to see if it has arrived undamaged. If you find any visible signs of damage, immediately contact the shipping company or your local BulbiTech distributor. Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn
BulbiCAM main parts unboxing
BulbiCAM main parts unboxing When you receive your BulbiCAM please visually inspect the package to see if it has arrived undamaged. If you find any visible signs of damage, immediately contact the shipping company or your local BulbiTech distributor. The BulbiCAM HMD and its accessories come in a hard case to protect its content. Share […]
Slowed Saccadic Reaction Times in Seemingly Normal Parts of Glaucomatous Visual Fields
In eye movement perimetry, peripheral stimuli are confirmed by goal-directed eye movements toward the stimulus. The saccadic reaction time (SRT) is regarded as an index of visual field responsiveness, whereas in standard automated perimetry (SAP), the visual field sensitivity is tested. Gijs Thepass, Hans Lemij, Koenraad Vermeer, Johan Pel & Hans Van Der Steen investigated […]
Bulbitech at Medica
News Bulbitech at Medica Bulbitech is proud to be part of the Norwegian pavilion that will attend Medica in Dusseldorf, Germany this year. Medica will be held from November 15-18, 2021. Glad to meet you there! NORSKE BEDRIFTER SATSER PÅ MEDICA 2021 Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn
Our company
Our Timeline
2015
Funding from public funds and private investors for technology development
2016
Technical R&D development on platform & hardware
2017
Company & software CE-certified
Funding from public funds and private investors to complete smaller prototype
2019
Finalist in the DNB Healthcare prize
2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Certified QMS according to ISO 13485
Hardware CE-certified
2021
Bulbitech is FDA registered under number D437315
Awarded € 2 million euro grant from Norwegian Research Council for clinical validation of tests
I find the BulbiCAM device to be fascinating and shaping the future leading trends in ophthalmology. It is simple and easy to use, modular and very ergonomic. With its advanced virtual reality technology and diagnostic and monitoring abilities for eye disorders, this will likely be a breakthrough technology in the daily practice of high turnover clinics.
Prof. Goran Petrovski
Department of Ophthalmology, Oslo University Hospital and University of Oslo, Norway, The opinions stated by Prof. Goran Petrovski are his own, and not related to the institution he works atI am impressed by the technology of your device and first of all I would like to congratulate you for trying to solve a combination of clinical problems that no device can reliably solve.